Press release - 16/10/2024 Sensitive Arm Prostheses A quantum sensor that can register nerve impulses without contact opens up new possibilities in prosthetics. Researchers at Fraunhofer IPA are developing together with the industrial partner Q.ANT the prototype of one Prosthetic arm that is controlled by neural commands like healthy limbs.https://www.gesundheitsindustrie-bw.de/en/article/press-release/sensitive-arm-prostheses
NMI project WOUNDSENS - 23/10/2024 Wound monitoring using sensory nanofibres Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
Event - 20/11/2024 DIS&CO Health | Market opportunities in Morocco Online , Registration deadline: 19/11/2024, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/dis-und-co-health-marktchancen-marokko
Advancing quantum technology into real-world applications - 06/11/2024 QSens: BMBF future cluster brings quantum sensors of the future into medicine The BMBF-funded future cluster ‘QSens – Quantum Sensors of the Future’ is developing ultra-sensitive sensors that could open up new options in medicine, enabling faster drug research, more accurate diagnostics and improved rehabilitation. The universities of Stuttgart and Ulm are actively working with 17 industry partners to put these cutting-edge innovations to immediate practical use.https://www.gesundheitsindustrie-bw.de/en/article/news/qsens-bmbf-future-cluster-brings-quantum-sensors-future-medicine
Press release - 05/11/2024 Heidelberg scientist receives highly endowed EC synergy grant Heidelberg scientist Dr Venera Weinhardt has received an ERC Synergy Grant for a pioneering biomedical research project. The European Research Council (ERC) is granting this funding to advance soft X-ray microscopy. This imaging technique along with other innovations will be used to investigate the hepatitis E virus. https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-scientist-receives-highly-endowed-ec-synergy-grant
Press release - 05/11/2024 How biomedical innovation improves preclinical research 3D tumor models, simulations of drug responses or plant stems used for testing heart stents: the 3R-BioMedicUS center at the University of Stuttgart is developing innovative biomedical approaches to improve preclinical studies, to be seen in the new video.https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-biomedical-innovation-improves-preclinical-research
Press release - 30/10/2024 Diabetes switch in DNA: Non-coding region in the genome influences ONECUT1 gene They are underestimated genetic control elements: it is known that changes in the genome can trigger diabetes. But now researchers at the University Hospital Ulm and the INSERM Cochin Institute in Paris have shown that a previously under-researched region of the genome also plays a crucial role in the development of this disease. https://www.gesundheitsindustrie-bw.de/en/article/press-release/diabetes-switch-dna-non-coding-region-genome-influences-onecut1-gene
The Baden-Württemberg healthcare industry At a glance https://www.gesundheitsindustrie-bw.de/en/facts-and-figures
The Baden-Württemberg healthcare industry The pharmaceutical industry https://www.gesundheitsindustrie-bw.de/en/location/pharma
The Baden-Württemberg healthcare industry Medical technology https://www.gesundheitsindustrie-bw.de/en/location/medtech
Press release - 15/11/2024 Selenium proteins as a possible new target for cancer research An important enzyme helps the body produce selenium proteins – this discovery could open up new strategies for treating cancer in children. This has been published by scientists from the University of Würzburg, the University Sao Paolo, the German Cancer Research Center (DKFZ) and the Heidelberg Stem Cell Institute HI-STEM*.https://www.gesundheitsindustrie-bw.de/en/article/press-release/selenium-proteins-possible-new-target-cancer-research
Event - 28/11/2024 Venture Capital Meet & Greet - Catalpa Ventures Online, Webinar https://www.gesundheitsindustrie-bw.de/en/event/venture-capital-meet-und-greet-catalpa-ventures
Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024
Greener NHS - 18/11/2024 National Health Service working towards climate neutrality The National Health Service (NHS) in the United Kingdom and Northern Ireland is taking steps to become more environmentally sustainable. The NHS has committed to the ambitious goal of achieving net zero carbon emissions by 2040, aiming to significantly reduce its climate impact in the coming years.https://www.gesundheitsindustrie-bw.de/en/article/news/national-health-service-working-towards-climate-neutrality
Press release - 15/11/2024 Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University. https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university
Press release - 14/11/2024 Novel method for fighting tumors Making existing cancer therapy more efficient while significantly reducing the side effects on healthy tissue - this is the aim of a project at Aalen University. It is being funded with one million euros from the Carl Zeiss Foundation. The biophysicist and his team are developing innovative nanoparticles made of gold. The particles use radiotherapy and chemotherapy simultaneously and kill the cancer cells in a targeted manner.https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-method-for-fighting-tumors
Press release - 20/11/2024 New bioengineering approaches for the automated production of complex organoids The reproducible and precise production of complex organoid models to simulate human organ malfunctions is the focus of an interdisciplinary research project at Heidelberg University. A research team from the life and engineering sciences is looking to combine the engineering of molecular systems with machine learning and automated production methods. https://www.gesundheitsindustrie-bw.de/en/article/press-release/neue-ansaetze-des-bio-engineering-fuer-die-automatisierte-herstellung-komplexer-organoide
Press release - 20/11/2024 Research team develops novel biomimetic speaking valve technology The challenge: if conventional speaking valves are used improperly, dangerous overpressure can occur, which can cause serious complications and even death. In a collaboration at the University of Freiburg, researchers developed a speaking valve with an integrated pressure release valve and an acoustic warning signal, inspired by the trapping mechanism of the carnivorous bladderwort plant Utricularia vulgaris.https://www.gesundheitsindustrie-bw.de/en/article/press-release/forschungsteam-entwickelt-neuartige-biomimetische-sprechventil-technologie
Press release - 20/11/2024 Millions in federal funding: customized 3D printing for patients in oral and maxillofacial surgery The German Federal Ministry of Education and Research (BMBF) is currently funding a project at the Department of Oral and Maxillofacial Surgery at Heidelberg University Hospital with around 1.2 million euros. The aim is to use 3D printing technology to produce individualized implants directly in the clinic, thus enabling faster, more efficient and more precise patient-specific care. To this end, the UKHD is working with an industrial partner.https://www.gesundheitsindustrie-bw.de/en/article/press-release/millions-federal-funding-customized-3d-printing-patients-oral-and-maxillofacial-surgery
The Baden-Württemberg healthcare industry The biotechnology sector https://www.gesundheitsindustrie-bw.de/en/location/biotech
Press release - 25/11/2024 Chromosomal chaos promotes therapy resistance in leukemia cells and opens up new treatment approaches Chromosomal instability plays a role in the progression of cancer: it shapes the properties of tumor cells and drives the development of therapy resistance. Scientists from the German Cancer Research Center (DKFZ), the Heidelberg Stem Cell Institute HI-STEM* and the European Molecular Biology Laboratory (EMBL) used state-of-the-art single-cell analysis methods to analyze the cellular heterogeneity of a specific form of acute myeloid leukemia. https://www.gesundheitsindustrie-bw.de/en/article/press-release/chromosomal-chaos-promotes-therapy-resistance-leukemia-cells-and-opens-new-treatment-approaches
Press release - 26/11/2024 Cellular “power plants” control inflammation Researchers at the Medical Center – University of Freiburg and the University’s CIBSS Cluster of Excellence discover how mitochondria not only produce energy but also influence inflammation.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cellular-power-plants-control-inflammation
Press release - 28/11/2024 Molecular biology: New interdisciplinary Research Training Group investigates cellular regulation Cell division, cell differentiation, cell repair and cell death play fundamental roles in the human organism, its development, health and reproduction. Cellular transformation processes are governed by two regulatory mechanisms: chromatin modifications and cell signaling networks. The EpiSignal Research Training Group sheds light on the hitherto little-researched interplay between these two complex systems.https://www.gesundheitsindustrie-bw.de/en/article/press-release/molecular-biology-new-interdisciplinary-research-training-group-investigates-cellular-regulation
Press release - 26/11/2024 Collaborative research centres on kidney and brain prolonged On 25 November, the German Research Foundation (DFG) announced the continued funding of two existing Collaborative Research Centres (CRC) at the University of Freiburg’s Faculty of Medicine. In CRC 1453 Nephrogenetics (NephGen), doctors and researchers are using genetic information to search for mechanisms underlying kidney diseases.https://www.gesundheitsindustrie-bw.de/en/article/press-release/collaborative-research-centres-kidney-and-brain-prolonged
Vicinity Bio: Optimisation of cancer diagnostics - 27/11/2024 Comprehensive histological diagnostics through high-dimensional imaging and artificial intelligence Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.https://www.gesundheitsindustrie-bw.de/en/article/news/Comprehensive-histological-diagnostics-through-high-dimensional-imaging-and-artificial-intelligence